Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Effectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load

Vista senzilla d'ítem
dc.contributor.authorImaz, Arkaitz
dc.contributor.authorLlibre, Josep María
dc.contributor.authorNavarro Bernabé, Joan
dc.contributor.authorCurto, J. J. (Jorge Juan)
dc.contributor.authorClotet, Bonaventura, 1953-
dc.contributor.authorCrespo, M.
dc.contributor.authorMurillo Rubio, Óscar
dc.contributor.authorFerrer, Elena
dc.contributor.authorSaumoy, Maria
dc.contributor.authorTiraboschi, Juan Manuel
dc.contributor.authorPodzamczer Palter, Daniel
dc.date.accessioned2018-11-27T11:38:22Z
dc.date.available2018-11-27T11:38:22Z
dc.date.issued2012-11-11
dc.date.updated2018-07-24T12:52:22Z
dc.description.abstractPurpose of the study: few clinical trials have compared non-nucleoside reverse transcriptase inhibitors (NNRTI) and ritonavir-boosted protease inhibitors (PI/r) as initial combined antiretroviral therapy (cART) for HIV-1-infected patients with high plasma viral load (pVL), and non-conclusive results have been reported. We compared the effectiveness between NNRTI and PI/r as first-line cART fof HIV-1-infected patients with high pVL.
dc.format.extent1 p.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/2445/126488
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.7448/IAS.15.6.18235
dc.relation.ispartofJournal of the International Aids Society, 2012, vol. 15, num. 18235, p. 147
dc.relation.urihttps://doi.org/10.7448/IAS.15.6.18235
dc.rightscc by (c) Imaz et al., 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationInfeccions per VIH
dc.subject.classificationAntiretrovirals
dc.subject.otherHIV infections
dc.subject.otherAntiretroviral agents
dc.titleEffectiveness of first-line antiretroviral therapy based on NNRTIs vs ritonavir-boosted PIs in HIV-1 infected patients with high plasma viral load
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Miniatura
Nom:
ImazA.pdf
Mida:
178.06 KB
Format:
Adobe Portable Document Format
Descarregar

Col·leccions

Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))